NCT05379738 Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy
| NCT ID | NCT05379738 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Haematological Malignancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2022-06-10 |
| Primary Completion | 2026-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2022-06-10 with a primary completion date of 2026-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is a study about adaptated physical activity for patients receiving a stem cell transplantation. They will benefit of 6 adaptated individuals lessons at home between 1 month and 3 months after stem cell transplantation. The study's goal is to observe if adaptated activity has an positive impact on weight loss and on life quality.
Eligibility Criteria
Inclusion criteria : * Patient aged 18 or more * Patient with social security * Patient who accept the study and sign the consent form * Patient programmed for an allogenic stem cell transplantation Non inclusion criteria : * Patients with a guardianship * Patients with a significant additional physic or mental disease Exclusion criteria * Patients who did not receive an allogeniac stem cell transplantation * Patients still hospitalized between day 30 and day 100 after stem cell transplantation * Patients who finally refuses the study * Patients who develop a physical or mental incapacity to practice physical activity
Contact & Investigator
SOLDATI Alizée
PRINCIPAL INVESTIGATOR
CHU NICE, hopital ARCHET 1, hématologie
Frequently Asked Questions
Who can join the NCT05379738 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Haematological Malignancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05379738 currently recruiting?
Yes, NCT05379738 is actively recruiting participants. Contact the research team at soldati.a@chu-nice.fr for enrollment information.
Where is the NCT05379738 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT05379738 clinical trial?
NCT05379738 is sponsored by Centre Hospitalier Universitaire de Nice. The principal investigator is SOLDATI Alizée at CHU NICE, hopital ARCHET 1, hématologie. The trial plans to enroll 75 participants.